Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00940 |
| Species: | Homo sapiens |
| Position : | chr11:5280741-5280786 |
| Year: | 2023 |
| Title: | High-sensitive nascent transcript sequencing reveals BRD4-specific control of widespread enhancer and target gene transcription |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 37591883 |
| MONDO: | MONDO:0011998 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K-562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Enhancer transcriptional regulation assay, Activity validation |
| High Throughput Method: | HiS-NET-seq, ChIP-Rx, HiChIP |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | HBB |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|